Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Francesca Foschini
Observed names:
F. Foschini,
Foschini, Francesca
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institutions:
Federico II University Hospital,
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
University of Naples Federico II
ORCID:
0000-0001-5389-7390
Observed ORCID:
0000-0001-5389-7390
OpenAlex ID:
A5019284296
Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review
2019
·
Fabiana Napolitano
, Luigi Formisano
, et al.
·
Cancers
·
50
PDF
FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules
2020
·
Francesca Foschini
, Fabiana Napolitano
, et al.
·
Therapeutic Advances in Medical Oncology
·
18
PDF
Randomized phase 2 study of valproic acid combined with simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic pancreatic adenocarcinoma patients: the VESPA trial study protocol
2024
·
Alfredo Budillon
, Alessandra Leone
, et al.
·
BMC Cancer
·
13
PDF
Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study
2023
·
C. Cardone
, A. De Stefano
, et al.
·
ESMO Open
·
8
A case report of limbic encephalitis in a metastatic colon cancer patient during first-line bevacizumab-combined chemotherapy
2018
·
Laura Attademo
, Stefano De Falco
, et al.
·
Medicine
·
6
The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer
2017
·
Carlo Buonerba
, Guru Sonpavde
, et al.
·
Journal of Cancer
·
6
PDF
Use of FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine for the Treatment of Locally Advanced Pancreatic Adenocarcinoma: A Single Institution Observational Study
2021
·
Alberto Servetto
, Antonio Santaniello
, et al.
·
Cancers
·
5
PDF
Heterogeneous disease and intermittent treatment in metastatic colorectal cancer: A case report
2023
·
Alfonso De Stefano
, Nicoletta Zanaletti
, et al.
·
Frontiers in Oncology
·
3
PDF
FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Adenocarcinoma: An Observational Study
2022
·
Alberto Servetto
, Antonio Santaniello
, et al.
·
Future Oncology
·
3
1753P Universal DPYD genotyping in patients with gastrointestinal malignancies: Real-world data from a single institution in Italy
2023
·
C. Cardone
, S. Facchini
, et al.
·
Annals of Oncology
·
1
PDF
Role of shrinkage in esophageal–gastric junction cancer
2023
·
Maddalena Leongito
, Raffaele Palaia
, et al.
·
Clinical Case Reports
·
1
PDF
FOLFIRINOX after first-line gemcitabine-based chemotherapy in metastatic pancreatic cancer: a mono-institutional experience
2019
·
F. Foschini
, L. Formisano
, et al.
·
Annals of Oncology
·
1
Exploring Body Composition Profiles in Patients with Gastrointestinal Cancers: A Cross-Sectional Analysis of the NUTRISCREEN Project
2026
·
Assunta Luongo
, Francesco Pio Maria Di Carlo
, et al.
·
Current Oncology
631eP Conversion surgery following chemo-immunotherapy in initially unresectable gastric and gastroesophageal junction adenocarcinoma: A multicenter retrospective study
2026
·
G. Arrichiello
, F. Foschini
, et al.
·
Annals of Oncology
PDF
Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase 2 study
2022
·
Cardone, Claudia
, De Stefano, Alfonso
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
P-68 Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): An academic, multicenter, single-arm, two-stage, phase 2 study
2022
·
C. Cardone
, M. Piccirillo
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
20
Citation count:
115
H-index:
6
I10-index:
3
Year
Topic
Type